# Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), Cambridge, MA – FDA Inspections

Source: https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/918c30c3-22a5-436f-88c1-6af91b2c575a

> Inspection records and compliance data for Alnylam Pharmaceuticals, Inc. in Cambridge, Massachusetts. 3 FDA inspections on record, 1 Form 483, last inspected September 09, 2022. Publicly traded as NASDAQ: ALNY.

---

## Details

- Name: Alnylam Pharmaceuticals, Inc.
- FEI Number: 3004080452
- Address Line 1: 300 3rd St
- City: Cambridge
- State: Massachusetts
- Zip Code: 02142
- Country Name: United States
- Address: 300 3rd St, Cambridge, Massachusetts 02142, United States
- Country: United States

## Stock

- Stock ticker: ALNY
- Exchange: NASDAQ
- Share price: $156.65
- Market cap: $21.0B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1181120 - Alnylam Pharmaceuticals, Inc. - 2022-09-09 — classification: No Action Indicated (NAI), source: FDA, date: September 9, 2022
- FDA Inspection 1107254 - Alnylam Pharmaceuticals, Inc. - 2019-09-18 — classification: No Action Indicated (NAI), source: FDA, date: September 18, 2019
- [EIR - Alnylam Pharmaceuticals, Inc. - 2018-04-25](https://www.keypedia.com/records/eir/alnylam-pharmaceuticals-inc/b6ab1f00-0732-4b7f-9e19-e203fc2dd074) — source: FDA, date: April 25, 2018
- [FDA Inspection 1050979 - Alnylam Pharmaceuticals, Inc. - 2018-04-25](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/416acd03-3f7b-46f1-a91a-64c29ee36158) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 25, 2018

## Related Companies

- [Aveo Pharmaceuticals Inc.](https://www.keypedia.com/companies/aveo-pharmaceuticals-inc/a2eaa018-1540-42fe-9d11-7e0e3b465daa)
- [Karyopharm Therapeutics Inc.](https://www.keypedia.com/companies/karyopharm-therapeutics-inc/28ffa225-b02c-40a0-8662-5bed25336a5a)
- [Partner Therapeutics, Inc.](https://www.keypedia.com/companies/partner-therapeutics-inc/02b6f3e3-ef3e-4352-9f94-1e462de5f2b4)
- [Citius Pharmaceuticals, Inc.](https://www.keypedia.com/companies/citius-pharmaceuticals-inc/1aa4934c-96a3-4ecb-a923-8ecd4e362d62)
- [Servier Pharmaceuticals, LLC.](https://www.keypedia.com/companies/servier-pharmaceuticals-llc/d72f7c9b-a32a-4c7c-97aa-89001e1341aa)
- [Verastem, Inc.](https://www.keypedia.com/companies/verastem-inc/d477d311-6bcc-4a68-ba12-e2255081e340)
- [Alexion Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015)
- [Blueprint Medicines Corporation](https://www.keypedia.com/companies/blueprint-medicines-corporation/92f765e6-81ff-46de-8cb1-dee7e91213fa)
- [Exemplar Pharmaceuticals LLC](https://www.keypedia.com/companies/exemplar-pharmaceuticals-llc/151a6f00-549b-403b-b79f-3d979f6246b5)
- [O'Barr, Thomas   MD](https://www.keypedia.com/companies/obarr-thomas-md/69a4b372-a12f-4261-82c4-385deb122204)

## Related Officers

- [recipient](https://www.keypedia.com/people/john-maraganore/04084c36-a939-40f0-84b9-c6be304cf230)
- [company_representative](https://www.keypedia.com/people/jeffrey-cehelsky/310173ab-0628-4e75-a199-ef497286bca5)
